Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$846M |
| 2 |
JD.com
JD
|
+$782M |
| 3 |
Dollar General
DG
|
+$647M |
| 4 |
Monster Beverage
MNST
|
+$324M |
| 5 |
NXP Semiconductors
NXPI
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$668M |
| 2 |
Mondelez International
MDLZ
|
+$528M |
| 3 |
Alibaba
BABA
|
+$457M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$409M |
| 5 |
CELG
Celgene Corp
CELG
|
+$403M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.97% |
| 2 | Consumer Discretionary | 16.01% |
| 3 | Technology | 12.95% |
| 4 | Communication Services | 12.43% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TTPH
326
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $53.3M | 0.05% |
56,141
+458
| +0.8% | +$374K |
|
|
FTRPR
327
DELISTED
Frontier Communications Corporation 11.125% Series A Mandatory Convertible Preferred Stock
FTRPR
| $53M | 0.05% |
+530,847
| New | +$53.3M |
|
|
B
328
Barrick Mining
B
$60.9B
| $52.7M | 0.05% |
4,943,793
+563,706
| +13% | +$6.87M |
|
329
Flex
FLEX
$37.7B
| $52.4M | 0.05% |
6,145,346
+10,272
| +0.2% | +$94.5K |
|
|
CYT
330
DELISTED
CYTEC INDS INC
CYT
| $52M | 0.05% |
859,792
+478,387
| +125% | +$27.8M |
|
331
Zurn Elkay Water Solutions
ZWS
$8.6B
| $51.9M | 0.05% |
4,507,810
+2,626
| +0.1% | +$33K |
|
|
PETX
332
DELISTED
Aratana Therapeutics, Inc.
PETX
| $51.9M | 0.05% |
3,431,787
+311,738
| +10% | +$4.5M |
|
333
Zimmer Biomet
ZBH
$18.8B
| $51.8M | 0.05% |
+488,361
| New | +$54M |
|
|
HOLX
334
DELISTED
Hologic
HOLX
| $51.5M | 0.05% |
1,354,230
-594,714
| -31% | -$20.8M |
|
|
PXD
335
DELISTED
Pioneer Natural Resource Co.
PXD
| $51.4M | 0.05% |
370,552
-2,882
| -0.8% | -$457K |
|
336
Ameren
AEE
$30.4B
| $51.1M | 0.05% |
1,357,375
-399,080
| -23% | -$16M |
|
|
CSOD
337
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $50.1M | 0.05% |
1,441,004
+27,611
| +2% | +$859K |
|
|
NFX
338
DELISTED
Newfield Exploration
NFX
| $50M | 0.05% |
1,384,071
+278,350
| +25% | +$10.4M |
|
339
Air Products & Chemicals
APD
$65.5B
| $49.5M | 0.05% |
391,286
+1,420
| +0.4% | +$194K |
|
|
BMS
340
DELISTED
Bemis
BMS
| $49.4M | 0.05% |
1,096,423
+422,550
| +63% | +$19.3M |
|
341
TechnipFMC
FTI
$28.6B
| $49.3M | 0.05% |
+1,596,775
| New | +$49.1M |
|
342
DuPont de Nemours
DD
$18.6B
| $49.3M | 0.05% |
+380,323
| New | +$49.3M |
|
343
Mercado Libre
MELI
$94.5B
| $49.2M | 0.05% |
347,512
+18,540
| +6% | +$2.62M |
|
344
UnitedHealth
UNH
$382B
| $48.4M | 0.04% |
397,000
+169,565
| +75% | +$20.1M |
|
345
Cadence Design Systems
CDNS
$91.8B
| $48M | 0.04% |
2,443,692
-14,203
| -0.6% | -$275K |
|
|
FOLD
346
DELISTED
Amicus Therapeutics
FOLD
| $47.7M | 0.04% |
+3,371,995
| New | +$40.5M |
|
|
DBD
347
DELISTED
Diebold Nixdorf Incorporated
DBD
| $47.5M | 0.04% |
1,357,636
-614,476
| -31% | -$21.7M |
|
348
Procter & Gamble
PG
$340B
| $47.1M | 0.04% |
602,464
-48,925
| -8% | -$3.94M |
|
349
Coca-Cola Europacific Partners
CCEP
$49.1B
| $47M | 0.04% |
+1,082,669
| New | +$48.6M |
|
|
ABGB
350
DELISTED
Abengoa SA Class B
ABGB
| $46.7M | 0.04% |
2,939,618
+521,882
| +22% | +$8.81M |
|
Similar funds
Jennison Associates's Q2 2015 Portfolio in Review
As of Q2 2015, Jennison Associates held 801 positions worth $109B, down 0.05% from $109B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jennison Associates's Q2 2015 filing shows 92 new, 315 increased, 305 reduced and 72 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M. The largest sale was Union Pacific, an estimated $668M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jennison Associates's largest Q2 2015 buy was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M.
- Jennison Associates added most to JD.com in Q2 2015, an estimated $782M increase.
- Jennison Associates's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $668M.
- Jennison Associates fully exited Perrigo in Q2 2015, selling an estimated $204M.
- Jennison Associates's ten largest holdings make up 21% of its $109B portfolio in Q2 2015.
- Jennison Associates opened 92 new positions and closed 72 in Q2 2015.
- Jennison Associates's portfolio value fell 0.05% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2015, filed 3 Aug 2015.